Taiwan Otsuka Pharmaceutical

otsuka.com.tw Revenue $278.3 Million Otsuka Pharmaceutical (Taiwan) Co., Ltd. Taiwanese arm of Japan's Otsuka Holdings (TSE: 4578), operating since 1974 — first as a JV, wholly owned since 1995. HQ in Taipei's Daan District with plants in Guandu and Kaohsiung, ~500–1,000 staff, capital NT$531M, president Ryoichi Fukumoto. Core business: prescription drugs (Abilify, Mucosta, nephrology/oncology lines), consumer brands (Pocari Sweat, Nature Made, CalorieMate, SOYJOY), medical devices, and a new insurance services arm. The group posted record 2025 pharma results (+22% revenue, +43% operating profit) across 84+ countries. Taiwan-specific financials aren't published (subsidiary of a listed parent), but the entity has 52 years on the market, TFDA-registered products, and a solid employer brand with active hiring since 2024.